Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide 3.0 mg on Weight Management in Children With Obesity Aged 6 to Below 12 Years
NCT04775082Phase 3Active, not recruiting
- Sponsor
- Novo Nordisk
- Start
- Mar 2021
- Primary completion
- Aug 2023
- Modality
- Peptides
- Countries
- 9
01
Overview
A Phase 3 trial of liraglutide in obesity, sponsored by Novo Nordisk. Started Mar 2021; status: active, not recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04775082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04775082.